Hypothermia protects retinal ganglion cells against hypoxia-induced cell death in a retina organ culture model
Standard
Hypothermia protects retinal ganglion cells against hypoxia-induced cell death in a retina organ culture model. / Klemm, Patricia; Hurst, José; Dias Blak, Matthias; Herrmann, Thoralf; Melchinger, Marion; Bartz-Schmidt, Karl U; Zeck, Günther; Schultheiss, Maximilian; Spitzer, Martin S; Schnichels, Sven.
In: CLIN EXP OPHTHALMOL, Vol. 47, No. 8, 11.2019, p. 1043-1054.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hypothermia protects retinal ganglion cells against hypoxia-induced cell death in a retina organ culture model
AU - Klemm, Patricia
AU - Hurst, José
AU - Dias Blak, Matthias
AU - Herrmann, Thoralf
AU - Melchinger, Marion
AU - Bartz-Schmidt, Karl U
AU - Zeck, Günther
AU - Schultheiss, Maximilian
AU - Spitzer, Martin S
AU - Schnichels, Sven
N1 - © 2019 Royal Australian and New Zealand College of Ophthalmologists.
PY - 2019/11
Y1 - 2019/11
N2 - BACKGROUND: Hypoxia contributes to retinal damage in several retinal diseases, including central retinal artery occlusion, with detrimental consequences like painless, monocular loss of vision. Currently, the treatment options are severely limited due to the short therapy window, as the neuronal cells, especially the retinal ganglion cells (RGCs), are irreversibly damaged within the first few hours. Hypothermia might be a possible treatment option or at least might increase the therapy window.METHODS: To investigate the neuroprotective effect of hypothermia after retinal hypoxia, an easy-to-use ex vivo retinal hypoxia organ culture model developed in our laboratory was used that reliably induced retinal damage on a structural, molecular and functional level. The neuroprotective effect of hypothermia after retinal hypoxia was analysed using optical coherence tomography scans, histological stainings, quantitative real-time polymerase chain reaction, western blotting and microelectrode array recordings.RESULTS: Two different hypothermic temperatures (30°C and 20°C) were evaluated, both exhibited strong neuroprotective effects. Most importantly, hypothermia increased RGC survival after retinal hypoxia. Furthermore, hypothermia counteracted the hypoxia-induced RGC death, reduced macroglia activation, attenuated retinal thinning and protected from loss of spontaneous RGC activity.CONCLUSIONS: These results indicate that already a mild reduction in temperature protects the RGCs against damage and could function as a promising therapeutic option for hypoxic diseases.
AB - BACKGROUND: Hypoxia contributes to retinal damage in several retinal diseases, including central retinal artery occlusion, with detrimental consequences like painless, monocular loss of vision. Currently, the treatment options are severely limited due to the short therapy window, as the neuronal cells, especially the retinal ganglion cells (RGCs), are irreversibly damaged within the first few hours. Hypothermia might be a possible treatment option or at least might increase the therapy window.METHODS: To investigate the neuroprotective effect of hypothermia after retinal hypoxia, an easy-to-use ex vivo retinal hypoxia organ culture model developed in our laboratory was used that reliably induced retinal damage on a structural, molecular and functional level. The neuroprotective effect of hypothermia after retinal hypoxia was analysed using optical coherence tomography scans, histological stainings, quantitative real-time polymerase chain reaction, western blotting and microelectrode array recordings.RESULTS: Two different hypothermic temperatures (30°C and 20°C) were evaluated, both exhibited strong neuroprotective effects. Most importantly, hypothermia increased RGC survival after retinal hypoxia. Furthermore, hypothermia counteracted the hypoxia-induced RGC death, reduced macroglia activation, attenuated retinal thinning and protected from loss of spontaneous RGC activity.CONCLUSIONS: These results indicate that already a mild reduction in temperature protects the RGCs against damage and could function as a promising therapeutic option for hypoxic diseases.
U2 - 10.1111/ceo.13565
DO - 10.1111/ceo.13565
M3 - SCORING: Journal article
C2 - 31152487
VL - 47
SP - 1043
EP - 1054
JO - CLIN EXP OPHTHALMOL
JF - CLIN EXP OPHTHALMOL
SN - 1442-6404
IS - 8
ER -